Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Becton, Dickinson Acquires Sirigen Group

RELATED NEWS
Trade BDX now with 

Becton, Dickinson and Co. (BDX: Quote) or BD announced that it has acquired Sirigen Group Limited, a developer of unique polymer dyes that are used in flow cytometry and can be applied to other technologies.

Sirigen's polymer technology is based on Nobel Prize-winning research in conductive plastics and creates the potential for the development of novel dyes that are four to ten times brighter than conventional dyes - a breakthrough in the field.

The financial terms of the acquisition were not disclosed. On a GAAP basis, the transaction is expected to be dilutive to fiscal 2012 earnings per share by approximately $0.01.

The company maintained its full year earnings per share outlook. The company still projects reported earnings per share from continuing operations for the fiscal year 2012 to be between $5.33 and $5.38. Analysts polled by Thomson Reuters expect the company to report earnings of $5.38 per share for fiscal 2012. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for Becton, Dickinson and Company and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A number of major retailers will be open on Thanksgiving for early Black Friday shopping events. Kohl's department stores will kick off Black Friday sales two hours earlier this year, at 6 p.m. Thanksgiving Day, while Macy's, Bon-Ton and Best Buy will open at the same time. J.C. Penney and Sears... Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps, will retain his vice president of product title and work on Twitter's geolocation features, the Wall... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.